Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -6.24-19.2051.689.98-5.38

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is -6.24 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar2026-6.24
Mar2025-19.20
Mar202451.68
Mar20239.98
Mar2022-5.38

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 -6.24
Negative
Mar2025 -19.2
Negative
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹821.2 Cr -5.7% -9.6% 2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,483.0 Cr -3.2% -7.8% 9% Stock Analytics
DIVIS LABORATORIES ₹249,248.0 Cr 1% 0.9% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,822.0 Cr -1.8% -4.8% 32.2% Stock Analytics
CIPLA ₹105,427.0 Cr -3.1% -6.5% -12.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,492.3 Cr -1.7% 3.1% -3.5% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-5.7%

-9.6%

2.6%

SENSEX

-1.2%

-6.4%

-10.8%


You may also like the below Video Courses